Showing results (261-270 of 391) with videos related to

Sort By:
Pageof 40
Gynecologic Oncology|July 12, 2014
Overall survival after pelvic exenteration for gynecologic malignancyShannon N Westin, Vijayashri Rallapalli, Bryan Fellman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 18, 2025
Hormone replacement therapy in gynecologic cancer: oncologic safety and alternative therapiesAna Luzarraga Aznar, Osnat Elyashiv, Susan Dababou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 9, 2010
Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smallerDennis S Chi, Joyce N Barlin, Pedro T Ramirez, et al.
Cancer Research|August 2, 2012
Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cellsCurdin Conrad, Josh Gregorio, Yi-Hong Wang, et al.
American Journal of Obstetrics and Gynecology|July 20, 2020
A prospective randomized trial comparing liposomal bupivacaine vs standard bupivacaine wound infiltration in open gynecologic surgery on an enhanced recovery pathwayLarissa A Meyer, Camila Corzo, Maria D Iniesta, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 14, 2026
Determinants of adjuvant radiotherapy in early-stage cervical cancer: a retrospective analysis of the SUCCOR cohortJvan Casarin, Tommaso Meschini, Gabriella Schivardi, et al.
Gynecologic Oncology|May 7, 2021
Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancerJeffrey A How, Shrina Patel, Bryan Fellman, et al.
Cancer|January 7, 2010
Pelvic fractures after radiotherapy for cervical cancer: implications for survivorsKathleen M Schmeler, Anuja Jhingran, Revathy B Iyer, et al.
Gynecologic Oncology|July 22, 2017
A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group studyJohn K Chan, Wei Deng, Robert V Higgins, et al.
Gynecologic Oncology|May 7, 2008
Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneumPedro T Ramirez, Kathleen M Schmeler, Michael R Milam, et al.
Pageof 40